首页> 外文期刊>Materials science & engineering >Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues
【24h】

Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues

机译:用于靶向核酸和化学治疗剂的新型多目标纳米颗粒,对乳腺癌组织进行核酸和化学治疗剂

获取原文
获取原文并翻译 | 示例
           

摘要

Selective delivery of drugs to damaged tissues favorable to reduce the side effects while enhancing the therapeutic efficacy. The purpose of the present study was the design and synthesis of multi-targeted nanoparticles for co-delivery of both drug and nucleic acid to cancer cells. In this study biocompatible compounds such as chitosan, polyethylene glycol (PEG), polycaprolactone (PCL), folic acid (FA) and glucose (Glu) were used to synthesize the FA-PEG-Chitosan-PCL-Chitosan-PEG-FA (FPCP) and Glu-PEG-Chitosan-PCL-Chitosan-PEG-Glu (GPCP) copolymers. Then, paclitaxel (PTX), oleic acid-coated FeCO nanoparticles (FeCO-OA) and 6-carboxy-fluorescein phosphoramidate (FAM)-labeled siRNA (siRNA-FAM) were encapsulated into either FPCP or GPCP, or both FPCP and GPCP (GFPCP), using the solvent evaporation technique.In vitro and in vivo biocompatibility and drug delivery efficiency of FPCP/FeCO-OA/PTX, GPCP/FeCO-OA/PTX and GFPCP/FeCO-OA/PTX nanoparticles were determined by recording the MTT assay, weight loss and tumor volume respectively. In addition, the ability of FPCP/FeCO-OA/siRNA-FAM, GPCP/FeCO-OA/siRNAFAM, and GFPCP/FeCO-OA/siRNA-FAM gene transfer was determined using flow cytometry analysis. Moreover, the effects of applying an external magnetic field to the tumor site on the efficiency of drug delivery using FPCP/FeCO-OA/siRNA-FAM/PTX (NPsA), GPCP/FeCO-OA/siRNA-FAM/PTX (NPsB) and GFPCP/FeCO-OA/siRNAFAM/PTX (NPsAB) were also investigated in the present study.No significant toxicity was observed for the FPCP and GPCP copolymers. Meanwhile, PTX encapsulated FPCP, GPCP and GFPCP exhibited greater anticancer activities against MCF-7 cells. The in vivo and in vitro results showed that the nanoparticles targeted with both folic acid and glucose increased drug and RNA transfer efficiency compared to when folic acid or glucose alone used. Also, the efficiency of PTX and siRNA-FAM delivery to tumor tissues by nanoparticles increased significantly by applying an external magnetic field to the tumor area. The hydrophobic interactions between different amphipathic copolymers in appropriate is an efficient and easy technique to synthesize complex and multifunctional nanoparticles.
机译:选择性地递送药物,以损坏有利的组织,以减少副作用,同时提高治疗效果。本研究的目的是用于将药物和核酸共同交付给癌细胞的多目标纳米颗粒的设计和合成。在该研究中,使用壳聚糖,聚乙二醇(PEG),聚己内酯(PCL),叶酸(FA)和葡萄糖(GLU)的生物相容性化合物合成FA-PEG-Chotosan-PCL-Chotosan-PEG-FA(FPCP )和Glu-Peg-壳聚糖-PCL-壳聚糖-PEG-GLU(GPCP)共聚物。然后,将油脂酸(PTX),油酸涂覆的FECO纳米颗粒(FECO-OA)和6-羧基 - 荧光素氨基膦酸盐(FAM)包封成FPCP或GPCP或FPCP和GPCP( GFPCP)使用溶剂蒸发技术。体外和体内生物相容性和FPCP / FECO-OA / PTX的药物输送效率,通过记录MTT测定GPCP / FECO-OA / PTX和GFPCP / FECO-OA / PTX纳米颗粒分别测定,减肥和肿瘤体积。此外,使用流式细胞术分析测定FPCP / FECO-OA / siRNA-FAM,GPCP / FECO-OA / SIRNAFAM和GFPCP / FECO-OA / siRNA-FAM基因转移的能力。此外,使用FPCP / FECO-OA / siRNA-FAM / PTX(NPSA),GPCP / FECO-OA / siRNA-FAM / PTX(NPSB)将外部磁场施加到肿瘤部位对肿瘤部位的影响还在本研究中研究了GFPCP / FECO-OA / SIRNAFAM / PTX(NPSAB)。对于FPCP和GPCP共聚物,观察到显着的毒性。同时,PTX包封的FPCP,GPCP和GFPCP对MCF-7细胞显示出更大的抗癌活动。体内和体外结果表明,与单独使用的叶酸或葡萄糖仅使用叶酸或葡萄糖时,靶向叶酸和葡萄糖的纳米颗粒增加。而且,通过将外部磁场施加到肿瘤区域,通过纳米颗粒对肿瘤组织的PTX和siRNA-FAM的效率显着增加。适当的不同两亲性共聚物之间的疏水相互作用是合成复合物和多官能纳米颗粒的有效且易于的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号